Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chris Morrison

Showing results (11-20 of 77) with videos related to

Pageof 8
Sort By:
Nature Biotechnology|June 10, 2015
CAR-T field booms as next-generation platforms attract big playersChris Morrison
Nature Biotechnology|May 5, 2019
Spark's meteoric rise from hospital-funded spinout to $4.8 billion dealChris Morrison
Nature Reviews. Drug Discovery|July 31, 2018
Constrained peptides' time to shine?Chris Morrison
Nature Biotechnology|October 9, 2015
Landmark green light for Mosquirix malaria vaccineChris Morrison
Nature Reviews. Drug Discovery|December 29, 2018
Boom: 2018's biotech IPOsChris Morrison
The Clinical Neuropsychologist|December 21, 2018
President's Annual State of the Academy ReportChris Morrison
The Clinical Neuropsychologist|January 10, 2017
Acting President's Annual State of the Academy ReportChris Morrison
Nature Biotechnology|November 9, 2016
Hope for anti-amyloid antibodies surges, yet againChris Morrison
Nature Reviews. Drug Discovery|March 2, 2017
Out-licensing role reversalChris Morrison
Nature Biotechnology|March 10, 2015
$1-million price tag set for Glybera gene therapyChris Morrison
Pageof 8

Showing results (11-20 of 77) with videos related to

Sort By:
Pageof 8
Nature Biotechnology|June 10, 2015
CAR-T field booms as next-generation platforms attract big playersChris Morrison
Nature Biotechnology|May 5, 2019
Spark's meteoric rise from hospital-funded spinout to $4.8 billion dealChris Morrison
Nature Reviews. Drug Discovery|July 31, 2018
Constrained peptides' time to shine?Chris Morrison
Nature Biotechnology|October 9, 2015
Landmark green light for Mosquirix malaria vaccineChris Morrison
Nature Reviews. Drug Discovery|December 29, 2018
Boom: 2018's biotech IPOsChris Morrison
The Clinical Neuropsychologist|December 21, 2018
President's Annual State of the Academy ReportChris Morrison
The Clinical Neuropsychologist|January 10, 2017
Acting President's Annual State of the Academy ReportChris Morrison
Nature Biotechnology|November 9, 2016
Hope for anti-amyloid antibodies surges, yet againChris Morrison
Nature Reviews. Drug Discovery|March 2, 2017
Out-licensing role reversalChris Morrison
Nature Biotechnology|March 10, 2015
$1-million price tag set for Glybera gene therapyChris Morrison
Pageof 8